[Possibilities and limits for treating psoriasis with biologics. Case reports]
- PMID: 18712323
- DOI: 10.1007/s00105-008-1571-6
[Possibilities and limits for treating psoriasis with biologics. Case reports]
Abstract
The availability of biologics for the therapy of psoriasis has radically changed the options for systemic therapy of this disease. Their use is often coupled with a variety of restrictions--as a rule they are to be used as a 'last-line' therapy. The status of previous systemic therapy as a basic requirement for the use of biologics is analyzed and simultaneously, the possibilities of the physician to use the indication spectrum of biologics for the benefit of the patient are demonstrated by case reports.
Similar articles
-
The role of biologics and other systemic agents in the treatment of pediatric psoriasis.Semin Cutan Med Surg. 2010 Mar;29(1):20-7. doi: 10.1016/j.sder.2010.01.003. Semin Cutan Med Surg. 2010. PMID: 20430304 Review. No abstract available.
-
Combining traditional systemic and biologic therapies for psoriasis.Semin Cutan Med Surg. 2010 Mar;29(1):67-9. doi: 10.1016/j.sder.2010.03.003. Semin Cutan Med Surg. 2010. PMID: 20430311 Review.
-
A new era in the management of psoriasis? The biologics: facts and controversies.Clin Dermatol. 2010 Jan-Feb;28(1):81-7. doi: 10.1016/j.clindermatol.2009.03.002. Clin Dermatol. 2010. PMID: 20082956 Review.
-
Practical experience of biologics for treatment of very severe psoriasis: a retrospective case cohort study of patients with a baseline Psoriasis Area and Severity Index greater than 20.Clin Exp Dermatol. 2016 Jan;41(1):95-6. doi: 10.1111/ced.12651. Epub 2015 Mar 28. Clin Exp Dermatol. 2016. PMID: 25817265 No abstract available.
-
The treatment of moderate-to-severe psoriasis: prescreening and monitoring psoriatic patients on biologics.Semin Cutan Med Surg. 2010 Mar;29(1):28-34. doi: 10.1016/j.sder.2010.02.003. Semin Cutan Med Surg. 2010. PMID: 20430305 Review.
Cited by
-
Nano-based formulations of thymoquinone are new approaches for psoriasis treatment: a literature review.Front Immunol. 2024 Aug 12;15:1416842. doi: 10.3389/fimmu.2024.1416842. eCollection 2024. Front Immunol. 2024. PMID: 39188726 Free PMC article. Review.
References
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Medical